Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial

Gisela Canedo Marroquin

doi:10.1101/2021.03.31.21254494

Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial

Facultad de Odontología

Research output: Other contribution › peer-review

Original language	English
DOIs	https://doi.org/10.1101/2021.03.31.21254494
State	Published - 1 Apr 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1101/2021.03.31.21254494

Cite this

@misc{9556192877da44a8877670ee050c64f8,

title = "Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial",

author = "{Canedo Marroquin}, Gisela",

year = "2021",

month = apr,

day = "1",

doi = "10.1101/2021.03.31.21254494",

language = "English",

type = "Other",

}

Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial

UN SDGs

Access to Document

Other files and links

Cite this